Upgrade to SI Premium - Free Trial

Pfizer (PFE), Merck KGaA Treat First Patient in Avelumab Phase 3 in RCC Setting

April 5, 2016 8:10 AM
Merck KGaA, Darmstadt, Germany, and Pfizer (NYSE: PFE) announced the treatment of the first patient in a Phase III study ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles